Coordination to Imidazole Ring Switches on Phosphorescence of Platinum Cyclometalated Complexes: The Route to Selective Labeling of Peptides and Proteins via Histidine Residues.

In this study, we have shown that substitution of chloride ligand for imidazole (Im) ring in the cyclometalated platinum complex Pt(phpy)(PPh3)Cl (1; phpy, 2-phenylpyridine; PPh3, triphenylphosphine), which is nonemissive in solution, switches on phosphorescence of the resulting compound. Crystallographic and nuclear magnetic resonance (NMR) spectroscopic studies of the substitution product showed that the luminescence ignition is a result of Im coordination to give the [Pt(phpy)(Im)(PPh3)]Cl complex. The other imidazole-containing biomolecules, such as histidine and histidine-containing peptides and proteins, also trigger luminescence of the substitution products. The complex 1 proved to be highly selective toward the imidazole ring coordination that allows site-specific labeling of peptides and proteins with 1 using the route, which is orthogonal to the common bioconjugation schemes via lysine, aspartic and glutamic acids, or cysteine and does not require any preliminary modification of a biomolecule. The utility of this approach was demonstrated on (i) site-specific modification of the ubiquitin, a small protein that contains only one His residue in its sequence, and (ii) preparation of nonaggregated HSA-based Pt phosphorescent probe. The latter particles easily internalize into the live HeLa cells and display a high potential for live-cell phosphorescence lifetime imaging (PLIM) as well as for advanced correlation PLIM and FLIM experiments.

Supramolecular Au(I)-Cu(I) Complexes as New Luminescent Labels for Covalent Bioconjugation.

Two new supramolecular organometallic complexes, namely, [Au6Cu2(C2C6H4CHO)6(PPh2C6H4PPh2)3](PF6)2 and [Au6Cu2(C2C6H4NCS)6(PPh2C6H4PPh2)3](PF6)2, with highly reactive aldehyde and isothiocyanate groups have been synthesized and characterized using X-ray crystallography, ESI mass spectrometry, and NMR spectroscopy. The compounds obtained demonstrated bright emission in solution with the excited-state lifetime in microsecond domain both under single- and two-photon excitation. The luminescent complexes were found to be suitable for bioconjugation in aqueous media. In particular, they are able to form the covalent conjugates with proteins of different molecular size (soybean trypsin inhibitor, human serum albumin, rabbit anti-HSA antibodies). The conjugates demonstrated a high level of the phosphorescent emission from the covalently bound label, excellent solubility, and high stability in physiological media. The highest quantum yield, storage stability, and luminance were detected for bioconjugates formed by covalent attachment of the aldehyde-bearing supramolecular Au(I)-Cu(I) complex. The measured biological activity of one of the labeled model proteins clearly showed that introduced label did not prevent the biorecognition and specific protein-protein complex formation that was extremely important for the application of the conjugates in biomolecular detection and imaging.

Sky-blue luminescent Au(I)-Ag(I) alkynyl-phosphine clusters.

Treatment of the (AuC2R)n acetylides with phosphine ligand 1,4-bis(diphenylphosphino)butane (PbuP) and Ag(+) ions results in self-assembly of the heterobimetallic clusters of three structural types depending on the nature of the alkynyl group. The hexadecanuclear complex [Au12Ag4(C2R)12(PbuP)6](4+) (1) is formed for R = Ph, and the octanuclear species [Au6Ag2(C2R)6(PbuP)3](2+) adopting two structural arrangements in the solid state were found for the aliphatic alkynes (R = Bu(t) (2), 2-propanolyl (3), 1-cyclohexanolyl (4), diphenylmethanolyl (5), 2-borneolyl (6)). The structures of the compounds 1-4 and 6 were determined by single crystal X-ray diffraction analysis. The NMR spectroscopic studies revealed complicated dynamic behavior of 1-3 in solution. In particular, complexes 2 and 3 undergo reversible transformation, which involves slow interconversion of two isomeric forms. The luminescence behavior of the titled clusters has been studied. All the compounds exhibit efficient sky-blue room-temperature phosphorescence both in solution and in the solid state with maximum quantum yield of 76%. The theoretical DFT calculations of the electronic structures demonstrated the difference in photophysical properties of the compounds depending on their structural topology.

The synthesis, structure and dynamic behaviour of disubstituted alkenylphosphine derivatives of [Rh6(CO)16].

A series of [Rh(6)(CO)(16)] substituted derivatives containing Ph(2)P(alkenyl) ligands has been synthesized starting from the [Rh(6)(CO)(16-x)(NCMe)(x)](x= 1, 2) clusters and Ph(2)P((CH(2))(n)CH=CH(2))(n= 2, 3) phosphines. It was shown that the terminal alkenyl substituents in these phosphines easily undergo isomerization in the coordination sphere of the hexarhodium complexes to give the allyl -CH(2)CH=C(H)R (R = Me and Et) fragments coordinated through the double bond of the rearranged organic moieties. The solid-state structure of two clusters, [Rh(6)(CO)(14)(mu2,kappa3-Ph(2)PCH(2)CH=C(H)CH(3))](4) and [Rh(6)(CO)(14)(mu2,kappa3-Ph(2)PCH(2)CH=C(H)CH(2)CH(3))](8), was established by X-ray crystallography. Solution structures of the products obtained were also characterized by IR and NMR ((1)H, (31)P, (1)H-(1)H COSY and (1)H-(1)H NOE) spectroscopy. It was shown that 4 and 8 exist in solution as mixtures of three isomers (A, B and C), which differ in the conformation of the coordinated allyl fragment. A similar (two species, A and B) equilibrium was found to occur in the solution of the [Rh(6)(CO)(14)(mu2,kappa3-Ph(2)PCH(2)CH=CH(2))](2) cluster. The dynamic behaviour of 2, 4 and 8[Rh(6)(CO)(14)(mu2,kappa3-Ph(2)PCH=CH(2))] has been studied using VT (31)P and (1)H-(1)H NOESY NMR spectroscopy, rate constants and activation parameters of the (A<-->B) isomerization processes were determined. It was shown that the most probable mechanism of this isomerization involves a dissociative [Rh6(CO)(14)(kappa1-Ph(2)P(alkenyl))] intermediate and re-coordination of the double bond to the same metal atom where the process started from. The conversion of the A and B species in and into the third isomer very likely occurs through the transfer of an allyl hydrogen atom onto the rhodium skeleton to give eventually cis conformation of the coordinated allyl fragment.